Candriam SCA’s ChemoCentryx, Inc. CCXI Stock Holding History

Candriam SCA’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-45,218	Closed	-$2.34M	–	907
2022 Q3	$2.34M	Buy	+45,218	New	+$1.87M	0.02%	558

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Candriam SCA's CCXI Position: Q4 2022 in Review

Candriam SCA sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 45,218 shares — an estimated $2.34M sold.

Candriam SCA first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $2.34M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Candriam SCA reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Candriam SCA sold 45,218 ChemoCentryx, Inc. shares in Q4 2022, an estimated $2.34M.
Candriam SCA first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
Candriam SCA's ChemoCentryx, Inc. position peaked at $2.34M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.